secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2025-08-08T23:59:59+00:00
Accession:  0001628280-25-039115
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave Q2 revenue $10.2M (+42% YoY), adjusted EBITDA $3.4M; guides Q3 $12-12.7M
--------------------------------------------------------------------------------

- Q2 2025 revenue $10.2M, +42% YoY from $7.2M; gross margin 78.3% vs 73.2%.
- GAAP operating income $1.9M (incl $1.1M stock comp) vs $2.0M prior; adjusted EBITDA $3.4M vs $1.5M.
- Sold 116 UltraMist systems in Q2 (vs 72 Q2 2024); consumables revenue $6.4M, +37% YoY.
- Q3 2025 revenue guidance $12-12.7M; full-year 2025 reaffirmed $48-50M (47-53% growth).
- CEO says full national sales coverage achieved mid-July, aiming for breakout performance in Q4 2025 and 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025039115/0001628280-25-039115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025039115/snwv-20250808.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-039115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer